Erectile Dysfunction Drugs Market - Global Industry Analysis
Erectile Dysfunction Drugs Market by Drug (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), by Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024
Published Date: 04-Oct-2018Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-3395
Status : Published
Global erectile dysfunction drugs market expected to generate revenue of around USD 7.10 billion by end of 2024, growing at a CAGR of around 5.70% between 2018 and 2024. The demand for erectile dysfunction drugs is highly growing due to the high incidence rate of chronic diseases including hypertension, neurogenic and psychological disorders, and diabetes.